drugset / Trial / NCT06559163
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).
Timeline
- Start
- 2024-09-17
- Primary completion
- 2026-06
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Obexelimab | Monoclonal antibody | — | Subcutaneous |